We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Collagen Solutions Plc | LSE:COS | London | Ordinary Share | GB00B94T6Y14 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.625 | 6.25 | 7.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMCOS
Collagen Solutions PLC
07 February 2017
Collagen Solutions Plc
(the "Company" or the "Group")
Collagen Solutions at the Medical Design and Manufacturing West Conference in Anaheim 7-9 February
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics will have representatives in attendance at the Medical Design and Manufacturing West (MD&M West) conference at the Anaheim Conference Centre in California, USA.
For 32 years, MD&M West has helped take medical devices from concept to market by uniting cutting-edge technology with the industry's foremost minds and represents the World's Largest Annual Medtech event.
It connects over 20,000 engineers and executives who are ready and willing to forge business partnerships.
Commenting on the MD&D West conference, Jamal Rushdy, CEO of Collagen Solutions said: "MD&M West is an important venue for us to demonstrate and communicate our in-house expertise in medical device development, gain first-hand understanding of what products and services are needed in numerous medical device markets, and further raise the profile of Collagen Solutions as a best-in-class manufacturer and developer of regenerative medicine devices based on our medical grade collagen and tissue technologies. Establishing this awareness is particularly important as we focus on programmes to bring finished devices to the market."
About Collagen Solutions:
Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The capabilities of the Company include the provision of native, soluble and powdered collagen formulations, processed and semi-processed tissues such as pericardium, bone, and blood vessels, and expertise in the development and contract manufacture of collagen components for use as engineered tissue scaffolds and other medical devices. These products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology. Collagen Solutions' unique offering extends beyond material supply and contract services through the highly skilled staff who support customers through the various stages of development and regulatory approval.
For additional information, please visit www.collagensolutions.com.
Enquiries:
Collagen Solutions Plc Contact via Walbrook Jamal Rushdy, Chief Executive Officer Gill Black, Chief Financial Officer Cenkos Securities plc (Nominated Tel: 0207 397 8900 Adviser and Broker) Stephen Keys Steve Cox Walbrook PR Tel: 020 7933 8780 or collagen@walbrookpr.com Mike Wort Mob: 07900 608 002 Anna Dunphy Mob: 07876 741 001
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAVQLFBDLFEBBV
(END) Dow Jones Newswires
February 07, 2017 02:00 ET (07:00 GMT)
1 Year Collagen Solutions Chart |
1 Month Collagen Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
